A pharmaceutical manufacturer receives a batch of active pharmaceutical ingredient that fails identity testing. What is the required disposition?
-
A
Retest using a different method before rejecting
-
B
Reject and return or destroy the material
-
C
Place in quarantine and notify the supplier only
-
D
Use under a deviation if potency is acceptable